Pressure Ulcers

Laurie Swezey's picture

by Laurie Swezey RN, BSN, CWOCN, CWS, FACCWS

This article is designed to provide a review of cellulitis, an infection affecting the skin which can be life-threatening if not treated.

What is cellulitis?

Cellulitis is the term used to describe inflammation of the skin and subcutaneous tissues, most often caused by acute infection. The two most common pathogens associated with cellulitis are Streptococcus pyogenes and Staphylococcus aureus.

Mary Ellen Posthauer's picture

by Mary Ellen Posthauer RDN, CD, LD, FAND

For the past two years I have been involved in the research and development of the second edition of the Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline. Members of the Pan Pacific Pressure Injury Alliance joined National Pressure Ulcer Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP) in producing a document that could be used by health professionals around the world.

Cheryl Carver's picture


A long-term care facility is paid thousands of dollars monthly to take care of our loved ones. This should assure us to feel a healthy sense of entitlement to quality of care. So why were there more than 2.5 million pressure ulcers reported by AHRQ in 2013? The cost of treating a single full-thickness pressure ulcer can now be estimated as high as $20,900 to $151,700. Pressure ulcers are not only exceedingly costly to treat, but prevention is by far cheaper. Yet, the economic impact is poorly recognized by many in the health service, as is the ability to make massive changes for a small investment.

Lindsay Andronaco's picture

by Lindsay D. Andronaco RN, BSN, CWCN, WOC, DAPWCA, FAACWS

Is your facility taking hospital-acquired pressure ulcers, or HAPUs, seriously? This has become a hot button issue for CMS over the last five years. I must say that I hear constant complaints about staffing issues and that is why the patient ended up with a HAPU. I can see how this may be one piece of the puzzle, but overall there are many other factors to why one gets a HAPU. From my experience as a wound care specialist and consultant, I feel that the reasoning for HAPUs is multifaceted.

Michel Hermans's picture

Part 2 in a series on clinical trials in wound care
For part 1,
click here.
by Michel H.E. Hermans, MD

In the first part of this series on the challenges of conducting clinical trials in wound care, I discussed factors that include patient populations and lesion prevalence. Additional criteria and conditions of the clinical trial will be further examined in this blog.

Paula Erwin-Toth's picture

by Paula Erwin-Toth MSN, RN, CWOCN, CNS, FAAN

Health care professionals recognize there seem to be 'seasons' for certain diseases and conditions. Spring and fall see a rise in flare ups of gastrointestinal disorders, such as inflammatory bowel diseases and seasonal allergies. Summer months bring an increase in traumatic events such as drownings, gunshot wounds and automobile accidents. Development of pressure ulcers does not follow a seasonal pattern—they occur at a higher than acceptable frequency throughout the year.

Michel Hermans's picture

Part 1 in a series on clinical trials in wound care
For part 2, click here

by Michel H.E. Hermans, MD

To do a Randomized Controlled Trial within a reasonable time frame, the disease to be studied should be common and the patient population large and accessible. In addition, preferably the effect of the treatment should be fast and specific.

In the pharmaceutical environment these circumstances often exist. Nearly 68 million people in the US suffer from hypertension1,2 and it should be easy to find patients for a clinical trial. The study objective is also relatively simple: lowering blood pressure (of course I am simplifying here).